» Articles » PMID: 29980611

Temporal Requirement for Pulmonary Resident and Circulating T Cells During Virulent Infection

Overview
Journal J Immunol
Date 2018 Jul 8
PMID 29980611
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The lung is a complex organ with anatomically distinct pools of T cells that play specific roles in combating infection. Our knowledge regarding the generation and/or maintenance of immunity by parenchymal or circulating T cells has been gathered from either persistent (>60 d) or rapidly cleared (<10 d) infections. However, the roles of these distinct T cell pools in infections that are cleared over the course of several weeks are not understood. Clearance of the highly virulent intracellular bacterium subspecies (Ftt) following pulmonary infection of immune animals is a protracted T cell-dependent process requiring ∼30-40 d and serves as a model for infections that are not acutely controlled. Using this model, we found that intranasal vaccination increased the number of tissue-resident CD4 effector T cells, and subsequent challenge of immune mice with Ftt led to a significant expansion of polyfunctional parenchymal CD4 effector T cells compared with the circulating pool. Despite the dominant in vivo response by parenchymal CD4 T cells after vaccination and challenge, circulating CD4 T cells were superior at controlling intracellular Ftt replication in vitro. Further examination in vivo revealed temporal requirements for resident and circulating T cells during Ftt infection. These requirements were in direct contrast to other pulmonary infections that are cleared rapidly in immune animals. The data in this study provide important insights into the role of specific T cell populations that will be essential for the design of novel effective vaccines against tularemia and potentially other agents of pulmonary infection.

Citing Articles

A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.

Whelan A, Flick-Smith H, Walker N, Abraham A, Levitz S, Ostroff G PLoS One. 2024; 19(5):e0294998.

PMID: 38713688 PMC: 11075878. DOI: 10.1371/journal.pone.0294998.


Current vaccine strategies and novel approaches to combatting Francisella infection.

Harrell J, Roy C, Gunn J, McLachlan J Vaccine. 2024; 42(9):2171-2180.

PMID: 38461051 PMC: 11095077. DOI: 10.1016/j.vaccine.2024.02.086.


Circulating T Cells Are Not Sufficient for Protective Immunity against Virulent .

Roberts L, Wehrly T, Leighton I, Hanley P, Lovaglio J, Smith B J Immunol. 2022; 208(5):1180-1188.

PMID: 35149529 PMC: 8881340. DOI: 10.4049/jimmunol.2100915.


Host Immunity and : A Review of Tularemia in Immunocompromised Patients.

Bahuaud O, Le Brun C, Lemaignen A Microorganisms. 2021; 9(12).

PMID: 34946140 PMC: 8707036. DOI: 10.3390/microorganisms9122539.


Cutting Edge: Lung-Resident T Cells Elicited by SARS-CoV-2 Do Not Mediate Protection against Secondary Infection.

Roberts L, Jessop F, Wehrly T, Bosio C J Immunol. 2021; 207(10):2399-2404.

PMID: 34607940 PMC: 8578432. DOI: 10.4049/jimmunol.2100608.


References
1.
Crane D, Scott D, Bosio C . Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia. PLoS One. 2012; 7(3):e33349. PMC: 3299770. DOI: 10.1371/journal.pone.0033349. View

2.
Laidlaw B, Zhang N, Marshall H, Staron M, Guan T, Hu Y . CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection. Immunity. 2014; 41(4):633-45. PMC: 4324721. DOI: 10.1016/j.immuni.2014.09.007. View

3.
Conlan J, Shen H, KuoLee R, Zhao X, Chen W . Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma-.... Vaccine. 2005; 23(19):2477-85. DOI: 10.1016/j.vaccine.2004.10.034. View

4.
Wu T, Hu Y, Lee Y, Bouchard K, Benechet A, Khanna K . Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J Leukoc Biol. 2013; 95(2):215-24. PMC: 3896663. DOI: 10.1189/jlb.0313180. View

5.
Anderson R, Crane D, Bosio C . Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Vaccine. 2010; 28(40):6562-72. PMC: 2939155. DOI: 10.1016/j.vaccine.2010.07.072. View